Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Shaldon

Nephron

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Nephron|December 2, 1998
Intravenous iron and anaemia in haemodialysis patientsS Shaldon
Nephron|January 1, 1981
Progress from haemodialysisS Shaldon
Nephron|January 1, 1974
Editorial: Symposium on dialysisS Shaldon, R E Crockett
Nephron|January 1, 1991
Survival and adequacy in long-term hemodialysisS Shaldon, K M Koch
Nephron|January 1, 1988
Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane?J Floege, C Granolleras, K M Koch, et al.
Nephron|January 1, 1974
Anemia of the regular hemodialysis patient and its treatmentK M Koch, W D Patyna, S Shaldon, et al.
Nephron|January 1, 1986
Human interleukin-1 production during hemodialysisM Bingel, G Lonnemann, S Shaldon, et al.
Nephron|January 1, 1988
Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranesM Bingel, G Lonnemann, K M Koch, et al.
Nephron|January 1, 1994
The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysisR Schindler, G Lonnemann, J Schäffer, et al.
Nephron|January 1, 1990
Renal elimination of beta-2-microglobulin and myoglobin in patients with normal and impaired renal functionJ Floege, M F Wilks, M Soose, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Nephron|December 2, 1998
Intravenous iron and anaemia in haemodialysis patientsS Shaldon
Nephron|January 1, 1981
Progress from haemodialysisS Shaldon
Nephron|January 1, 1974
Editorial: Symposium on dialysisS Shaldon, R E Crockett
Nephron|January 1, 1991
Survival and adequacy in long-term hemodialysisS Shaldon, K M Koch
Nephron|January 1, 1988
Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane?J Floege, C Granolleras, K M Koch, et al.
Nephron|January 1, 1974
Anemia of the regular hemodialysis patient and its treatmentK M Koch, W D Patyna, S Shaldon, et al.
Nephron|January 1, 1986
Human interleukin-1 production during hemodialysisM Bingel, G Lonnemann, S Shaldon, et al.
Nephron|January 1, 1988
Plasma interleukin-1 activity during hemodialysis: the influence of dialysis membranesM Bingel, G Lonnemann, K M Koch, et al.
Nephron|January 1, 1994
The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysisR Schindler, G Lonnemann, J Schäffer, et al.
Nephron|January 1, 1990
Renal elimination of beta-2-microglobulin and myoglobin in patients with normal and impaired renal functionJ Floege, M F Wilks, M Soose, et al.
Pageof 2